{"id":1140,"date":"2023-09-26T19:00:00","date_gmt":"2023-09-26T11:00:00","guid":{"rendered":"https:\/\/wingor.abvnet.com\/%e5%88%9b%e6%96%b0%e6%8d%b7%e6%8a%a5%ef%bc%81%e8%8c%b5%e5%86%a0%e7%94%9f%e7%89%a9%e7%ac%ac%e4%ba%8c%e6%ac%be%e5%b9%b2%e7%bb%86%e8%83%9e%e6%96%b0%e8%8d%af%e4%b8%b4%e5%ba%8a%e8%af%95%e9%aa%8c%ef%bc%88in\/"},"modified":"2026-05-27T22:01:47","modified_gmt":"2026-05-27T14:01:47","slug":"%e5%88%9b%e6%96%b0%e6%8d%b7%e6%8a%a5%ef%bc%81%e8%8c%b5%e5%86%a0%e7%94%9f%e7%89%a9%e7%ac%ac%e4%ba%8c%e6%ac%be%e5%b9%b2%e7%bb%86%e8%83%9e%e6%96%b0%e8%8d%af%e4%b8%b4%e5%ba%8a%e8%af%95%e9%aa%8c%ef%bc%88in","status":"publish","type":"post","link":"https:\/\/wingor.abvnet.com\/en\/news\/%e5%88%9b%e6%96%b0%e6%8d%b7%e6%8a%a5%ef%bc%81%e8%8c%b5%e5%86%a0%e7%94%9f%e7%89%a9%e7%ac%ac%e4%ba%8c%e6%ac%be%e5%b9%b2%e7%bb%86%e8%83%9e%e6%96%b0%e8%8d%af%e4%b8%b4%e5%ba%8a%e8%af%95%e9%aa%8c%ef%bc%88in\/","title":{"rendered":"Breaking news! Innovent Biologics' Investigational New Drug (IND) application for its second stem cell drug has been accepted!"},"content":{"rendered":"
\n
\n<\/p>\n
\n
\n
\n

\"\"\"\"<\/p>\n

2023\u5e749\u670826\u65e5\uff0c\u7531\u6df1\u5733\u5e02\u8335\u51a0\u751f\u7269\u79d1\u6280\u6709\u9650\u516c\u53f8\u81ea\u4e3b\u7814\u53d1\u7684I\u7c7b\u751f\u7269\u5236\u54c1\u201c\u4eba\u8110\u5e26\u95f4\u5145\u8d28\u5e72\u7ec6\u80de\u6ce8\u5c04\u6db2\u201d\u65b0\u836f\u4e34\u5e8a\u8bd5<\/span>\u9a8c (Investigational new drug, IND)\u7533\u8bf7\u83b7\u5f97\u56fd\u5bb6\u836f\u54c1\u76d1\u7763\u7ba1\u7406\u5c40\uff08NMPA\uff09\u836f\u54c1\u5ba1\u8bc4\u4e2d\u5fc3\uff08CDE\uff09\u53d7\u7406\uff08\u53d7\u7406\u53f7\uff1aCXSL2300656\uff09\u3002<\/span><\/p>\n

\u672c\u6b21\u662f\u8335\u51a0\u751f\u7269\u7b2c\u4e8c\u6b3e\u7ec6\u80de\u836f\u7269IND\u83b7\u53d7\u7406\uff0c<\/span>\u5b9e\u73b0\u4e86<\/span>\u201c\u4ece\u96f6\u5230\u4e00\uff0c<\/span>\u4ece\u4e00\u5230\u4e8c\u201d\u7684\u8fde\u7eed\u7a81\u7834\uff0c<\/span>\u6807\u5fd7\u7740\u8335\u51a0\u751f\u7269<\/span>\u5e72\u7ec6\u80de\u836f\u7269\u7814\u53d1\u6ce8\u518c<\/span>\u9a76\u4e0a\u5feb\u8f66\u9053\u3002<\/span><\/p>\n

\"\"<\/section>\n

\u25b2CDE\u5b98\u7f51\uff1a\u8335\u51a0\u751f\u7269\u201c\u4eba\u8110\u5e26\u95f4\u5145\u8d28\u5e72\u7ec6\u80de\u6ce8\u5c04\u6db2\u201dIND\u7533\u8bf7\u53d7\u7406\u516c\u793a<\/span><\/p>\n

\n
\n
\n
CDE\uff0c\u5373\u56fd\u5bb6\u836f\u54c1\u76d1\u7763\u7ba1\u7406\u5c40\u836f\u54c1\u5ba1\u8bc4\u4e2d\u5fc3\uff0c\u662f\u56fd\u5bb6\u98df\u54c1\u836f\u54c1\u76d1\u7763\u7ba1\u7406\u5c40\u836f\u54c1\u6ce8\u518c\u6280\u672f\u5ba1\u8bc4\u673a\u6784\uff0c\u6309\u7167\u56fd\u5bb6\u98df\u54c1\u836f\u54c1\u76d1\u7763\u7ba1\u7406\u5c40\u9881\u5e03\u7684\u836f\u54c1\u6ce8\u518c\u7ba1\u7406\u6709\u5173\u89c4\u7ae0\uff0c\u8d1f\u8d23\u7ec4\u7ec7\u5bf9\u836f\u54c1\u6ce8\u518c\u7533\u8bf7\u8fdb\u884c\u6280\u672f\u5ba1\u8bc4\uff0c\u7ec4\u7ec7\u5f00\u5c55\u76f8\u5173\u7684\u7efc\u5408\u8bc4\u5ba1\u5de5\u4f5c\u3002<\/span><\/section>\n
\u00a0<\/section>\n
IND\uff0c\u5373\u65b0\u836f\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u662f\u836f\u7269\u7814\u53d1\u4f01\u4e1a\u4ee5\u6ce8\u518c\u76ee\u7684\uff0c\u5728\u836f\u54c1\u6b63\u5f0f\u4e0a\u5e02\u524d\uff0c\u5411CDE\u63d0\u4f9b\u8db3\u591f\u4fe1\u606f\u6765\u8bc1\u660e\u836f\u54c1\u5728\u4eba\u4f53\u8fdb\u884c\u8bd5\u9a8c\u662f\u5b89\u5168\u7684\uff0c\u4ee5\u53ca\u8bc1\u660e\u9488\u5bf9\u7814\u7a76\u76ee\u7684\u7684\u4e34\u5e8a\u65b9\u6848\u8bbe\u8ba1\u662f\u5408\u7406\u7684\u800c\u5f00\u5c55\u7684\u4eba\u4f53\u4e34\u5e8a\u8bd5\u9a8c\u3002<\/span><\/section>\n<\/section>\n<\/section>\n<\/blockquote>\n
\u622a\u81f3\u76ee\u524d\uff0c\u8335\u51a0\u751f\u7269\u5df2\u5efa\u7acb\u5341\u4f59\u6761\u521b\u65b0\u751f\u7269\u533b\u836f\u7814\u53d1\u7ba1\u7ebf\uff0c\u5177\u5907\u68af\u6b21\u4ea7\u51fa\u6001\u52bf\u3002\u8335\u51a0\u751f\u7269\u5c06\u575a\u6301\u521b\u65b0\u9a71\u52a8\uff0c\u6301\u7eed\u52a0\u7801\u7814\u53d1\u6295\u5165\uff0c\u51ed\u501f\u4e30\u5bcc\u7684\u62a5\u836f\u7ecf\u9a8c\uff0c\u4ee5\u89e3\u51b3\u672a\u88ab\u6ee1\u8db3\u7684\u4e34\u5e8a\u9700\u6c42\u4e3a\u4e2d\u5fc3\uff0c<\/span>\u6709\u5e8f\u63a8\u8fdb\u591a\u5143\u5316\u751f\u7269\u533b\u836f\u4ea7\u54c1\u8fdb\u5165\u4e34\u5e8a\u7684\u8fdb\u7a0b\uff0c\u65e9\u65e5\u60e0\u53ca\u5e7f\u5927\u75c5\u60a3\u3002<\/span><\/section>\n
\u00a0<\/section>\n

\u00a0<\/p>\n<\/div>\n<\/div>\n<\/div>\n

\n<\/div>\n<\/div>\n

\n
\n<\/p>\n
\n
\n
\n
\n
\n
<\/div>\n<\/div>\n
\n
<\/div>\n
\n
\n <\/div>\n
<\/div>\n
<\/div>\n<\/div><\/div>\n<\/div>\n<\/div>\n

<\/p>\n

\n
\n <\/p>\n
<\/div>\n<\/div>\n<\/div>\n

<\/p>\n


\n <\/i>
\n <\/span><\/div>\n

\n <\/i>
\n <\/span><\/div>\n<\/p><\/div>\n<\/div>\n

<\/p>\n<\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"

2023\u5e749\u670826\u65e5\uff0c\u7531\u6df1\u5733\u5e02\u8335\u51a0\u751f\u7269\u79d1\u6280\u6709\u9650\u516c\u53f8\u81ea\u4e3b\u7814\u53d1\u7684I\u7c7b\u751f\u7269\u5236\u54c1\u201c\u4eba\u8110\u5e26\u95f4\u5145\u8d28\u5e72\u7ec6\u80de\u6ce8\u5c04\u6db2\u201d\u65b0\u836f\u4e34\u5e8a\u8bd5… Read More »Breaking news! Innovent Biologics' Investigational New Drug (IND) application for its second stem cell drug has been accepted!<\/span><\/a><\/p>","protected":false},"author":1,"featured_media":1141,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"","neve_meta_content_width":0,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","footnotes":""},"categories":[37],"tags":[],"class_list":["post-1140","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-gsdt"],"desktop_mode_lock":null,"desktop_mode_contributors":[],"_links":{"self":[{"href":"https:\/\/wingor.abvnet.com\/en\/wp-json\/wp\/v2\/posts\/1140","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/wingor.abvnet.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/wingor.abvnet.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/wingor.abvnet.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/wingor.abvnet.com\/en\/wp-json\/wp\/v2\/comments?post=1140"}],"version-history":[{"count":0,"href":"https:\/\/wingor.abvnet.com\/en\/wp-json\/wp\/v2\/posts\/1140\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/wingor.abvnet.com\/en\/wp-json\/wp\/v2\/media\/1141"}],"wp:attachment":[{"href":"https:\/\/wingor.abvnet.com\/en\/wp-json\/wp\/v2\/media?parent=1140"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/wingor.abvnet.com\/en\/wp-json\/wp\/v2\/categories?post=1140"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/wingor.abvnet.com\/en\/wp-json\/wp\/v2\/tags?post=1140"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}